Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MOREWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MOREUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don’t find the answers you’re looking for, contact us for additional assistance.
EXPLORE MOREThe vaccine is a biological agent that enhances immunity to a particular disease. Over time, it has evolved from traditional prophylactic uses to more complicated therapeutic products. The cancer vaccine development is a pathway from discovery research to clinical evaluation of putative protective antigens. The process is unique, capital intensive and risky. Given the significance of safety with biologics, the vaccine industry is highly valued.
Fig.1 Life cycle of modern vaccine development. (Kaufmann, 2014)
There are a lot of challenges in the field of cancer vaccine development. it is essential to be in balance with cost, risks, and benefits besides finding safe and effective antigens, adjuvants, and delivery systems. Today, Creative Biolabs makes efforts to meet the steadily growing demands for novel cancer vaccines and accelerate vaccine design, development, and manufacturing through international collaboration and continuous innovation of technologies.
Development of every vaccine starts at the exploratory stage. The goal of therapeutic cancer vaccines is to induce immunity activities against tumor-associated antigens (TAAs), which fall into two categories: tumor-specific shared antigens and tumor-specific unique antigens.
Cancer vaccine developments can be divided into two stages, pre-clinical and clinical development. Pre-clinical studies comprise laboratory and animal experiments. In the clinical stage, the vaccines are tested in humans and this process takes four phases and lasts for many years. Currently, we hope to introduce the following services to allow for a more streamlined and profitable vaccine development.
Creative Biolabs supports cancer vaccine development in both the pre-clinical and clinical phases. Our unique combination of expertise makes us an ideal partner to facilitate clients’ vaccine research from the identification of potential targets, analysis of immune responses, to assessment in animal models.
Cancer vaccines are made in the same way as other biologicals, but with higher standards, to ensure the purity and quality of final products. Every step from the beginning must be confirmed and the whole process of manufacture must be carried out in a clean, safe, and controlled environment.
In Creative Biolabs, cancer vaccines are prepared following Good Manufacturing Practices (GMP) and our cleanrooms are a part of GMP regulations for vaccine development. The circumstance of humidity, air, and temperature in this room are controlled along with the number of entering people simultaneously. According to the requirements, we can meet three GMP standards, including ISO, EU, and US-FDA, and we can deal with different issues in vaccine production.
General GMP concerns for upstream; Raw material preparation; Cell culture; Virus culture; Inactivation of microorganisms.
General GMP concerns for downstream; (ultra) Filtration techniques; (ultra) Centrifugation techniques; Sterile filtration and aseptic processing.
Vaccination remains the most cost-effective public health intervention, whose benefits extremely outweigh the costs. Here, Creative Biolabs can offer multiple products and services in the process development of cancer vaccines, GMP manufacturing, and analytical testing, as well as assist clients in pre-clinical and clinical research to support vaccine commercialization.
For more information on the solutions of vaccine-related services, please contact us by e-mail.
Reference
All services and products are only for lab research use, not for any clinical diagnosis or treatment.
For any technical issues or products/services related questions, please leave your information below. Our team will contact you soon.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.
LEARN MORE
Angiotensin-converting Enzyme 2 (ACE2)-CHO Cell Line Model for COVID-19: Helps researchers to further study the interaction between the receptor ACE2 and the COVID-19 virus.
LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.
LEARN MORE
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE
